How GPCR agonists, including antibodies, are shaping the future of metabolic care
Find out how Confo Therapeutics is overcoming challenges in GPCR drug development to create next-gen therapies for metabolic diseases.
List view / Grid view
Find out how Confo Therapeutics is overcoming challenges in GPCR drug development to create next-gen therapies for metabolic diseases.
CNIC researchers have identified a mechanism in fat cells that helps them safely store excess fat, offering new insights for combating obesity and related metabolic diseases.
The relationship between insulin and ageing in flies could have far-reaching implications for diabetes and obesity drugs for humans.
Announced at the International Investment Summit, Lilly plan to support early-stage life sciences businesses to develop therapeutics for significant health challenges.
This study is first to demonstrate with statistical certainty that human visceral adipose tissue accumulated in the abdominal cavity secretes more extracellular vesicles.
The study highlights the possible therapeutic significance of targeting the pathway for treating obesity and metabolic disease.
In this article, senior leaders at SFA Therapeutics emphasise the importance of re-establishing homeostasis in drug development approaches.
Heightened insulin resistance in obese men may elucidate the higher prevalence of type 2 diabetes among these individuals.
The discovery that omental fat has a mechanism to limit adipocyte formation may lead to new treatments for obesity and metabolic disease.
The new study found T3s treatment exhibited neuroprotective effects in HFSD-fed mice by mitigating oxidative stress.
Researchers have gained a deeper understanding of the neural biology of obesity, which could offer potential drug targets.
New findings show that age-related MC4R+ cilia shortening causes middle-aged obesity and leptin resistance, which could lead to obesity treatment.
Researchers found that resolvinT4 restores protective macrophage biological activities in rheumatoid arthritis patients.
Excessive insulin levels in people with obesity and type 2 diabetes overstimulates pancreatic cells, initiating disease.
New Study from King's College London: Irregular Sleep Patterns Tied to Harmful Gut Bacteria.